Abstract
Sudden infant death syndrome (SIDS) is defined as the sudden and unexpected death of an apparently healthy infant under 1 year of age. Routine autopsies often provide few clues as to the cause of death and rarely include a biochemical evaluation. Genetic counseling for SIDS can be difficult as recurrence risks vary depending on the age at death and the number of deaths which have occurred in the family. Biochemical disorders may account for up to 5% of SIDS. Of the metabolic disorders known to be involved in SIDS, the most commonly found is medium-chain acyl CoA dehydrogenase deficiency (MCAD). MCAD is an autosomal recessive disorder of fatty acid oxidation which accounts for up to 1% of SIDS. For some families, the addition of a postmortem biochemical investigation can identify an unsuspected metabolic disorder as the cause of death. Once the diagnosis is established, accurate genetic counseling can then be provided. Metabolic testing of the surviving siblings of victims of sudden death, and the subsequent identification of those due to MCAD can prevent the tragedy of recurrent SIDS in some families. In addition, screening the survivors of an acute life threatening event (ALTE) may also prevent a recurrence.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beal S, Blundell H (1988) Recurrence incidence of sudden infant death syndrome.Arch Dis Childhood 63:924–930.
Bennett M, Variend S, Pollitt R (1986) Screening siblings for inborn errors of fatty acid metabolism in families with a history of sudden infant death.Lancet 1470.
Bennett M, Allison F, Pollitt R, Manning N, Gray R, Green A, Hale D, Coates PM (1987) Prenatal diagnosis of medium-chain acyl CoA dehydrogenase deficiency in a family with sudden infant death.Lancet 1:440.
Bergman A, Beckwith J, Ray C (1970)Sudden Infant Death Syndrome. Seattle: University of Washington Press.
Carpenter R, Gardner A, Harris J, Judd M, Lewry J, Maddock CR, Powell J, Taylor EM (1988)Ann NY Acad Sci 533:96–103.
DeFrain JD, Ernst L (1978) The psychological effects of sudden infant death syndrome on surviving family members.J Fam Pract 6:985–989.
Ding JH, Roe CR, Iafolla AK, Chen YT (1991) Diagnosis of medium-chain acyl CoA dehydrogenase deficiency in children dying suddenly without explanation by mutation analysis in postmortem fixed tissue.New Engl J Med 325:61–62.
Ding JH, Yang BZ, Bao Y, Roe CR, Chen YT (1992a) Identification of a new mutation in medium-chain acyl CoA dehydrogenase (MCAD) deficiency.Am J Hum Genet 50:229–233.
Ding JH, Bross P, Yang BZ, Iafolla AK, Millington DS, Roe CR, Gregersen N, Chen YT (1992b) Genetic heterogeneity in MCAD deficiency: Frequency of K329E allele and identification of three additional mutant alleles. In: Coates PM, Tanaka K (eds)New Developments in Fatty Acid Oxidation. New York: Wiley-Liss.
Dyregrov A, Matthiesen S. (1987) Anxiety and vulnerability in parents following the death of an infant.Scand J Psychol 28:16–25.
Harpey JP, Charpentier C, Paturneau-Jouas M (1990) Sudden infant death syndrome and inherited disorders of fatty acid beta oxidation.Biol Neonate 58(Suppl 1):70–80.
Hodgman J, Hoppenbrouwers T (1988) Home monitoring for the sudden infant death syndrome: The case against.Ann NY Acad. Sci 533:164–175.
Hoffman H, Damus K, Hillman L, Krongrad E (1988) Risk factors for SIDS: Results of the National Institute of Child Health and Human Development SIDS cooperative epidemiological study.Ann NY Acad Sci 533:13–30.
Iafolla AK, Millington D, Chen YT, Ding JH, Kahler S, Roe C (1991) Natural course of medium-chain acyl CoA dehydrogenase deficiency (MCAD).Am J Hum Genet 49(Suppl):99.
Irgens L, Skjaerven R, Peterson D (1984) Prospective assessment of recurrence risk in sudden infant death syndrome siblings.J Pediat 104:349–351.
Kelly D (1988) Home monitoring of the sudden infant death syndrome: The case for.Ann NY Acad Sci 533:158–163.
Kelly D, Whelan A, Ogden M, Alpers R, Zhang Z, Bellus G, Gregersen N, Dorland L, Strauss A (1990) Molecular characterization of inherited medium-chain acyl CoA dehydrogenase deficiency.Proc Natl Acad Sci 87:9236–9240.
Matsubara Y, Kraus J, Yang-Feng T, Franke U, Rosenberg L, Tanaka K (1986) Molecular cloning of cDNAs encoding rat and human medium-chain acyl CoA dehydrogenase and assignment of the gene to human chromosome 1.Proc Natl Acad Sci 83:6543–6547.
Matsubara Y, Narisawa K, Tada K (1992) Medium-chain acyl CoA dehydrogenase deficiency: Molecular aspects.Eur J Pediat 151:154–159.
Millington DS, Kodo N, Norwood DL, Roe CR (1990) Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism.J Inher Metabol Dis 13:321–324.
Millington DS, Kodo N, Terada N, Roe D, Chace DH (1991) The analysis of diagnostic markers of genetic disorders in human blood and urine using tandem mass spectrometry with liquid secondary ion mass spectrometry.Int J Mass Spectrum Ion Proc 111:211–228.
Oren J, Kelly D, Shannon D (1987) Familial occurrence of sudden infant death syndrome and apnea of infancy. Pediatrics 80:355–357.
Peterson D, Chinn N, Fisher L (1980) The sudden infant death syndrome: Repetitions in families.J Pediat 97:265–267.
Peterson D, Sabotta E, Daling J (1986) Infant mortality among subsequent siblings of infants who died of sudden infant death syndrome.J Pediat 108:911–914.
Pollitt R (1989) Disorders of mitochondrial beta oxidation: Prenatal and early postnatal diagnosis and their relevance to Reye's syndrome and sudden infant death.J Inher Metabol Dis 12:(Suppl 1)215–230.
Rinaldo P, O'Shea JJ, Coates PM, Hale DE, Stanley CA, Tanaka K (1988) Medium-chain acyl-CoA dehydrogenase deficiency: Diagnosis by stable-isotope dilution measurement of urinaryn-hexanoylglycine and 3-phenylpropionylglycine.New Engl J Med 19:1308–1313.
Roe C, Coates PM (1989) Acyl CoA dehydrogenase deficiencies. In: Scriver C (ed)The Metabolic Basis of Inherited Disease. New York: McGraw-Hill, pp 889–914.
Roe CR, Millington D, Maltby D, Kinnebrew P (1986) Recognition of medium chain acyl CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye like syndromes.J Pediat 108:13–18.
Sinclair-Smith C, Dinsdale F, Emery J (1976) Evidence of duration and type of illness in children found unexpectedly dead.Arch Dis Child 51:424–249.
Stanley CA, Hale DE, Coates PM, Hall CL, Corkey BE, Yang W, Kelley RI, Gonzales EL, Williamson JR, Baker L (1983) Medium-chain acyl-CoA dehydrogenated deficiency in children with non-ketotic hypoglycemia and low carnitine levels.Pediat Res 17:877–884.
Stanley CA, Hale D, Coates PM (1990) Medium chain acyl CoA dehydrogenase deficiency. In:Fatty Acid Oxidation: Clinical, Biochemical, and Molecular Aspects. New York: Alan R. Liss, pp. 291–302.
Tanaka K, Yokota I, Coates P, Strauss AW, Kelly DP, Zhang Z, Gregersen N, Andersen BS, Matsubara Y, Curtis D, and Chen Y-T. (in press) Mutations in the medium Chain Acyl-CoA dehydrogenated (MCAD) gene.Hum Mutat.
Vance J, Foster W, Najman J, Embelton G, Thearle M, Hodgen F (1991) Early parental responses to sudden infant death, stillbirth or neonatal death.Med J Austr 155:292–297.
Van Hove JLK, Terada N, Zhang W, Chase DH, Kahler SG, Iafolla AK, Roe CR, Ding J-H, Chen Y-T, Millington DS (submitted) Medium chain acyl-CoA dehydrogenase deficiency: Diagnosis by acylcarnitine analysis in blood.Am J Hum Genet.
Wright A (1988) Models of mystery: Physician and patient perceptions of sudden infant death syndrome.Soc Sci Med 26:587–595.
Yokota I, Tanaka K, Coates PM, Ugarte M (1991) Mutations in medium chain acyl-CoA dehydrogenase deficiency.Lancet 2:748.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McConkie-Rosell, A., Iafolla, A.K. Medium-chain acyl CoA dehydrogenase deficiency: Its relationship to SIDS and the impact on genetic counseling. J Genet Counsel 2, 17–27 (1993). https://doi.org/10.1007/BF00962557
Issue Date:
DOI: https://doi.org/10.1007/BF00962557